Terms: = Endocrine gland cancer AND PIK3CA, MGC142161, 5290, ENSG00000121879, P42336, MGC142163, p110-alpha, PI3K AND Staging
18 results:
1. Biological functions of LncRNA SNHG14 in the development of thyroid cancer cells via targeting miR-206.
Sang Y; Min R; Huang T; Zhang J
Cell Mol Biol (Noisy-le-grand); 2024 Apr; 70(4):77-84. PubMed ID: 38678623
[TBL] [Abstract] [Full Text] [Related]
2. Extrauterine Mesonephric-like Carcinoma: A Comprehensive Single Institution Study of 33 Cases.
Euscher ED; Marques-Piubelli ML; Ramalingam P; Wistuba I; Lawson BC; Frumovitz M; Malpica A
Am J Surg Pathol; 2023 Jun; 47(6):635-648. PubMed ID: 37026792
[TBL] [Abstract] [Full Text] [Related]
3. [Ductal adenocarcinoma of the pancreas: subtypes and molecular pathology].
Schlitter AM; Konukiewitz B; Kasajima A; Reichert M; Klöppel G
Pathologe; 2021 Sep; 42(5):464-471. PubMed ID: 34402977
[TBL] [Abstract] [Full Text] [Related]
4. Clear cell carcinoma of the ovary: Epidemiology, pathological and biological features, treatment options and clinical outcomes.
Gadducci A; Multinu F; Cosio S; Carinelli S; Ghioni M; Aletti GD
Gynecol Oncol; 2021 Sep; 162(3):741-750. PubMed ID: 34247767
[TBL] [Abstract] [Full Text] [Related]
5. Determination of Potential Therapeutic Targets and Prognostic Markers of Ovarian cancer by Bioinformatics Analysis.
Zhang J; Huang S; Quan L; Meng Q; Wang H; Wang J; Chen J
Biomed Res Int; 2021; 2021():8883800. PubMed ID: 33829065
[TBL] [Abstract] [Full Text] [Related]
6. POTEE stimulates the proliferation of pancreatic cancer by activating the pi3k/Akt/GSK-3β/β-catenin signaling.
Hao Q; Gao L; Niu W; Chen L; Zhang P; Chen Z
Biofactors; 2020 Jul; 46(4):685-692. PubMed ID: 32589786
[TBL] [Abstract] [Full Text] [Related]
7. Inhibition of Ca
Liu Z; Zhang S; Hou F; Zhang C; Gao J; Wang K
Int J Cancer; 2019 May; 144(9):2215-2226. PubMed ID: 30243029
[TBL] [Abstract] [Full Text] [Related]
8. Molecular Markers Involved in Tumorigenesis of Thyroid Carcinoma: Focus on Aggressive Histotypes.
Penna GC; Vaisman F; Vaisman M; Sobrinho-Simões M; Soares P
Cytogenet Genome Res; 2016; 150(3-4):194-207. PubMed ID: 28231576
[TBL] [Abstract] [Full Text] [Related]
9. Expression of CD44 in pancreatic cancer and its significance.
Li XP; Zhang XW; Zheng LZ; Guo WJ
Int J Clin Exp Pathol; 2015; 8(6):6724-31. PubMed ID: 26261555
[TBL] [Abstract] [Full Text] [Related]
10. Mutational status of KRAS, NRAS, and BRAF in primary clear cell ovarian carcinoma.
Zannoni GF; Improta G; Chiarello G; Pettinato A; Petrillo M; Scollo P; Scambia G; Fraggetta F
Virchows Arch; 2014 Aug; 465(2):193-8. PubMed ID: 24889043
[TBL] [Abstract] [Full Text] [Related]
11. pi3k-AKT-mTOR-signaling and beyond: the complex network in gastroenteropancreatic neuroendocrine neoplasms.
Briest F; Grabowski P
Theranostics; 2014; 4(4):336-65. PubMed ID: 24578720
[TBL] [Abstract] [Full Text] [Related]
12. The involvement of RhoA and Wnt-5a in the tumorigenesis and progression of ovarian epithelial carcinoma.
Chen S; Wang J; Gou WF; Xiu YL; Zheng HC; Zong ZH; Takano Y; Zhao Y
Int J Mol Sci; 2013 Dec; 14(12):24187-99. PubMed ID: 24351810
[TBL] [Abstract] [Full Text] [Related]
13. Loss of ARID1A expression and its relationship with pi3k-Akt pathway alterations and ZNF217 amplification in ovarian clear cell carcinoma.
Huang HN; Lin MC; Huang WC; Chiang YC; Kuo KT
Mod Pathol; 2014 Jul; 27(7):983-90. PubMed ID: 24336158
[TBL] [Abstract] [Full Text] [Related]
14. Lewis Y regulates signaling molecules of the transforming growth factor β pathway in ovarian carcinoma-derived RMG-I cells.
Li FF; Liu JJ; Liu DW; Lin B; Hao YY; Cong JP; Zhu LC; Gao S; Zhang SL; Iwamori M
Int J Oncol; 2012 Apr; 40(4):1196-202. PubMed ID: 22179544
[TBL] [Abstract] [Full Text] [Related]
15. The role of phosphatidylinositol 3-kinase signaling pathways in pancreatic cancer.
Sun C; Rosendahl AH; Andersson R; Wu D; Wang X
Pancreatology; 2011; 11(2):252-60. PubMed ID: 21625196
[TBL] [Abstract] [Full Text] [Related]
16. Is the pik3ca gene expression level in FNAB washouts equivalent to that in postoperative tissue specimens of papillary thyroid carcinoma?
Wojciechowska-Durczynska K; Krawczyk-Rusiecka K; Cyniak-Magierska A; Zygmunt A; Dedecjus M; Lewinski A
Neuro Endocrinol Lett; 2011; 32(1):59-63. PubMed ID: 21407159
[TBL] [Abstract] [Full Text] [Related]
17. Lewis y antigen promotes the proliferation of ovarian carcinoma-derived RMG-I cells through the pi3k/Akt signaling pathway.
Liu J; Lin B; Hao Y; Qi Y; Zhu L; Li F; Liu D; Cong J; Zhang S; Iwamori M
J Exp Clin Cancer Res; 2009 Dec; 28(1):154. PubMed ID: 20003467
[TBL] [Abstract] [Full Text] [Related]
18. [Expression of phosphatidylinositol-3 kinase in epithelial ovarian carcinoma].
Zhang PN; Sun H
Zhonghua Fu Chan Ke Za Zhi; 2007 Mar; 42(3):196-200. PubMed ID: 17537308
[TBL] [Abstract] [Full Text] [Related]